Published in
American Society of Hematology, Blood Advances, 16(6), p. 4719-4725, 2022
DOI: 10.1182/bloodadvances.2022007776
Links
Tools
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
Journal article published in 2022 by
Kai Rejeski 
,
Andreas Burchert,
Gloria Iacoboni ,
Pierre Sesques,
Lars Fransecky ,
Veit Bücklein ,
Corinna Trenker,
Rafael Hernani ,
Ralph Naumann,
Jonas Schäfer ,
Viktoria Blumenberg ,
Christian Schmidt,
Kristina Sohlbach,
Michael von Bergwelt-Baildon,
Emmanuel Bachy
and other authors.
,
Andreas Burchert,
Gloria Iacoboni ,
Pierre Sesques,
Lars Fransecky ,
Veit Bücklein ,
Corinna Trenker,
Rafael Hernani ,
Ralph Naumann,
Jonas Schäfer ,
Viktoria Blumenberg ,
Christian Schmidt,
Kristina Sohlbach,
Michael von Bergwelt-Baildon,
Emmanuel Bachy
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 